MEDICINE OVERVIEW OF Hetriva 18 Transdermal Patch
THERAPEUTIC CLASS OF Hetriva 18 Transdermal Patch
WHY Hetriva 18 Transdermal Patch IS PRESCRIBED
Substitutes for - Hetriva 18 Transdermal Patch
HOW IT WORKS
HOW TO TAKE
WHEN TO TAKE
Hetriva 18 Transdermal Patch Warnings
Precautions of Hetriva 18 Transdermal Patch
Contraindications of Hetriva 18 Transdermal Patch
Side Effects of Hetriva 18 Transdermal Patch
Alcohol Interaction
Food to Avoid
Pregnancy/Lactation Protocol
Storage of Hetriva 18 Transdermal Patch
- Doctor's Note Required for this item
- Country of Origin: India
- Expires on: Sep 2026
- 14 days Return Policy
- Manufacturer Details
-
Seller Information:
Rivastigmine 18mg/patch, in vivo release rate 9.5mg/hr.

Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics and information, contained on or available through this website is for general information purposes only. SastaSundar.com makes no representation and assumes no responsibility for the accuracy of information contained on or available through this website and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources and review all information regarding any medical condition or treatment with your physician. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEBSITE.
SastaSundar.com does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, procedures, treatments, opinions or other information that may be contained on or available through this website.